Fresenius Kabi USA, LLC v. Dr. Reddys Laboratories, Inc.
1:16-cv-00169
Overview
Parties
Defendant
Dr. Reddys Laboratories, Ltd. Operating Company
Represented By
2 Attorneys ListedSmith, Katzenstein, & Jenkins LLP
The Brandywine Building, 1000 West Street, Suite 1501
Smith, Katzenstein, & Jenkins LLP
1000 West Street, Suite 1501, Wilmington, DE 19801
Dr. Reddys Laboratories, Inc. Operating Company
Represented By
2 Attorneys ListedSmith, Katzenstein, & Jenkins LLP
The Brandywine Building, 1000 West Street, Suite 1501
Smith, Katzenstein, & Jenkins LLP
1000 West Street, Suite 1501, Wilmington, DE 19801
Plaintiff
Fresenius Kabi USA, LLC Operating Company
Represented By
3 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
Mylan Institutional Inc. v. Fresenius Kabi USA, LLC
Mylan Institutional Inc. v. Fresenius Kabi USA LLC
Mylan Institutional Inc. v. Fresenius Kabi USA, LLC
Fresenius Kabi USA, LLC v. Maia Pharmaceuticals, Inc.
Fresenius Kabi USA, LLC v. Dr. Reddys Laboratories, Inc.
Fresenius Kabi USA, LLC v. Maia Pharmaceuticals, Inc.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9006289
Levothyroxine formulations
|
Filed: 2012-08-29
Issued: 2015-04-14
|
Active (5.9 yrs remaining)
+35d PTA
Expires: 2032-10-03
|
|
|
US9168238
Levothyroxine formulations
|
Filed: 2015-03-08
Issued: 2015-10-27
|
Active (8.3 yrs remaining)
Expires: 2035-03-08
|
|
|
US9168239
Levothyroxine formulations
|
Filed: 2015-03-13
Issued: 2015-10-27
|
Active (8.3 yrs remaining)
Expires: 2035-03-13
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
2
Dispositive
2
Granted
0
Denied
0
Pending / Review
2
Motions by Category
Key Dispositive Motions & Rulings